Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death 3. The Job Market for 2008-2009: Compensation 4. Renal Artery Stenosis 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
Aggregated LDL in contact with macrophages induces local increases in free cholesterol levels that regulate local actin polymerization
Arteriosclerosis, Thrombosis, and Vascular Biology, 06/29/09
Grosheva I et al. – Results describe a novel process during aggregated LDL (agLDL)–macrophage interactions in which local release of free cholesterol causes local actin polymerization, promoting a pathological positive feedback loop for increased catabolism of agLDL and eventual foam cell formation.
Methods- Study of whether engagement of agLDL by macrophages leads to local increases in free cholesterol levels and whether these increases in free cholesterol regulate signals that control cellular actin
- AgLDL resides for prolonged periods in surface-connected compartments
- agLDL remains extracellular
- An increase in free cholesterol occurs at sites of contact between agLDL and cells due to hydrolysis of agLDL-derived cholesteryl ester
- Increased free cholesterol causes enhanced actin polymerization around agLDL
- Inhibition of cholesteryl ester hydrolysis results in decreased actin polymerization
Today in Atherosclerosis/Lipids...keeping you current
Receive free subspecialty "5-minute updates" via email
Effects of prescription omega-3-acid ethyl esters on lipoprotein particle concentrations, apolipoproteins AI and CIII, and lipoprotein-associated phospholipase A2 mass in statin-treated subjects with hypertriglyceridemia
Journal of Clinical Lipidology, 10/14/09
Prevalence of Unresponsiveness to Aspirin and/or Clopidogrel in Patients With Stable Coronary Heart Disease
The American Journal of Cardiology, 10/21/09
Thinking beyond low-density lipoprotein cholesterol: strategies to further reduce cardiovascular risk
Vascular Health and Risk Management, 09/22/09
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial
The Lancet, 10/27/09
Obesity-Related Cardiorenal Syndrome
The Journal of Clinical Hypertension, 10/20/09
Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis
Arthritis Care and Research , 11/03/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


